New research from Rutgers University identifies a small increase in the risk of ischemic optic neuropathy among patients taking GLP-1 medications like Ozempic and Wegovy.
Researchers have identified a hidden lymphatic pathway in the back of the eye that clears metabolic waste, challenging century-old assumptions about ocular biology.
